India to Thailand: Gliclazide Export Trade Route
India has recorded 19 verified shipments of Gliclazide exported to Thailand, representing a combined trade value of $6.2M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $325.8K USD. The leading Indian exporter is PANACEA BIOTEC PHARMA LIMITED, which accounts for 99% of total export value with 9 shipments worth $6.1M USD. On the buying side, M/S. BIOGENETECH CO. LTD, is the largest importer in Thailand with $5.7M USD in purchases. The top 3 suppliers — PANACEA BIOTEC PHARMA LIMITED, INVENTIA HEALTHCARE LIMITED, STALLION LABORATORIES PVT LTD — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Thailand Gliclazide corridor is one of India's established pharmaceutical export routes, with 19 shipments documented worth a combined $6.2M USD. The route is dominated by PANACEA BIOTEC PHARMA LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's gliclazide manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $325.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 25.5%, placing it at rank #3 among India's top gliclazide export destinations globally.
On the import side, key buyers of Indian gliclazide in Thailand include M/S. BIOGENETECH CO. LTD,, BIOGENETECH CO. LTD,, M S BIOGENETECH CO LIMITED and 8 others. M/S. BIOGENETECH CO. LTD, is the single largest importer with 1 shipments valued at $5.7M USD.
Route Characteristics
- Average transit26 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portDELHI AIR
Market Position
- Global rank#3
- Annual growth+25.5%
- Demand growth+21.5%
- Regulatory ease67/100
Top 10 Indian Gliclazide Exporters to Thailand
Showing top 10 of 7 Indian suppliers exporting Gliclazide to Thailand, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PANACEA BIOTEC PHARMA LIMITED Avg $678.3K per shipment | 9 | $6.1M | 98.6% |
| 2 | INVENTIA HEALTHCARE LIMITED Avg $10.8K per shipment | 2 | $21.5K | 0.3% |
| 3 | STALLION LABORATORIES PVT LTD Avg $10.4K per shipment | 2 | $20.7K | 0.3% |
| 4 | KAUSIKH THERAPEUTICS PRIVATE LIMITED Avg $5.1K per shipment | 3 | $15.3K | 0.2% |
| 5 | VEE EXCEL DRUGS AND PHARMACEUTICALS PRIVATE LIMITE Avg $12.5K per shipment | 1 | $12.5K | 0.2% |
| 6 | ASMOH LABORATORIES LIMITED Avg $9.5K per shipment | 1 | $9.5K | 0.2% |
| 7 | PHARMA ALACRITY LLP Avg $5.7K per shipment | 1 | $5.7K | 0.1% |
This table shows the top 10 of 7 Indian companies exporting gliclazide to Thailand, ranked by total trade value. The listed exporters are: PANACEA BIOTEC PHARMA LIMITED, INVENTIA HEALTHCARE LIMITED, STALLION LABORATORIES PVT LTD, KAUSIKH THERAPEUTICS PRIVATE LIMITED, VEE EXCEL DRUGS AND PHARMACEUTICALS PRIVATE LIMITE, ASMOH LABORATORIES LIMITED, PHARMA ALACRITY LLP. PANACEA BIOTEC PHARMA LIMITED is the dominant supplier with 9 shipments worth $6.1M USD, giving it a 99% market share. The top 3 suppliers together account for 99% of the total trade value on this route.
Top 10 Gliclazide Importers in Thailand
Showing top 10 of 11 known buyers in Thailand receiving Gliclazide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian gliclazide in Thailand include M/S. BIOGENETECH CO. LTD,, BIOGENETECH CO. LTD,, M S BIOGENETECH CO LIMITED, REAL VALUE THERAPY PHARMACEUTICALS, VITAL PHARMACEUTICAL CO, LTD., among 11 total buyers. The largest importer is M/S. BIOGENETECH CO. LTD,, accounting for $5.7M USD across 1 shipments — representing 92% of all gliclazide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | M/S. BIOGENETECH CO. LTD, | 1 | $5.7M | 92.4% |
| 2 | BIOGENETECH CO. LTD, | 5 | $202.0K | 3.3% |
| 3 | M S BIOGENETECH CO LIMITED | 3 | $182.1K | 2.9% |
| 4 | REAL VALUE THERAPY PHARMACEUTICALS | 2 | $21.5K | 0.3% |
| 5 | VITAL PHARMACEUTICAL CO, LTD. | 1 | $15.3K | 0.2% |
| 6 | SCGM COMPANY LIMITED | 1 | $12.5K | 0.2% |
| 7 | AMETHYST CO LIMITED | 2 | $11.8K | 0.2% |
| 8 | TO THE ORDER | 1 | $9.5K | 0.2% |
| 9 | HTUN THAUK THIT CO., LTD | 1 | $5.7K | 0.1% |
| 10 | KYAW YADANA TRADING CO. LTD (KYT) | 1 | $5.5K | 0.1% |
Showing top 10 of 11 Gliclazide importers in Thailand on this route.
Top 10 Gliclazide Formulations Imported by Thailand
Showing top 10 of 14 product formulations shipped on the India to Thailand Gliclazide route, ranked by trade value
Thailand imports a wide range of gliclazide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — GLIZID M TABLETS (EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE IP 500 MG) B/N.01823003 M/ — accounts for $5.7M USD across 1 shipments. There are 14 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLIZID M TABLETS (EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE IP 500 MG) B/N.01823003 M/ | 1 | $5.7M | 92.4% |
| 2 | GLIZYM M TABLETS EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE IP 500 MG B/N.01823001 B/ | 3 | $182.1K | 2.9% |
| 3 | GLIZID M TABLETS (EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE BP 500 MG) B/N.01824007 & | 1 | $70.9K | 1.1% |
| 4 | GLIZID M TABLETS (EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE IP 500 MG) B/N.01824001 & | 3 | $67.5K | 1.1% |
| 5 | GLIZID-M TABLETS (EACH UNCOATED TABLET CONTAINS GLICLAZIDE BP 80 MG + METFORMINHYDROCHLORIDE BP 500 MG) B/N.01824005 M/ | 1 | $63.6K | 1.0% |
| 6 | PHARMACEUTICAL DRUGS & MEDICINES ANZIDE30 (GLICLAZIDE MODIFIED-RELEASE TABLETS30MG)(AS PER INVOICE) | 1 | $15.3K | 0.2% |
| 7 | PHARMACEUTICAL PRODUCTS - Gliclazide Modified Release Tablets 60 mg (MelliglizeXL 60 ) Batch No. G250015/2 , G250015/3, | 1 | $12.5K | 0.2% |
| 8 | GLICLAZIDE 80MG TABS 8X400X10X10+1X100X10X103300 BOX | 2 | $11.8K | 0.2% |
| 9 | GLITROL CR 60 ( GLICLAZIDE CONTROLLED RELEASE CAPSULES 60 MG) (PACK SIZE: 3 X 10) | 1 | $11.7K | 0.2% |
| 10 | GLITROL CR 30 ( GLICLAZIDE CONTROLLED RELEASE CAPSULES 30 MG) (PACK SIZE: 3 X 10) | 1 | $9.8K | 0.2% |
Showing top 10 of 14 Gliclazide formulations imported by Thailand on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
DELHI AIR handles the highest volume with 6 shipments. Transit time averages 26 days by sea.
Market Dynamics
India's gliclazide exports to Thailand are driven primarily by a handful of large-scale manufacturers. PANACEA BIOTEC PHARMA LIMITED with 9 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Thailand benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — PANACEA BIOTEC PHARMA LIMITED, INVENTIA HEALTHCARE LIMITED, STALLION LABORATORIES PVT LTD — together account for 99% of total trade value on this route. The average shipment value of $325.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as glizym m tablets each uncoated tablet contains gliclazide bp 80 mg + metforminhydrochloride ip 500 mg b/n.01823001 b/ and glizid m tablets (each uncoated tablet contains gliclazide bp 80 mg + metforminhydrochloride bp 500 mg) b/n.01824007 &, suggesting that buyers in Thailand tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, M/S. BIOGENETECH CO. LTD, is the largest importer with 1 shipments worth $5.7M USD — representing 92% of all gliclazide imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $6.2M
- Avg. Shipment
- $325.8K
- Suppliers
- 7
- Buyers
- 11
- Transit (Sea)
- ~26 days
- Annual Growth
- +25.5%
Related Analysis
Other Gliclazide Routes
Unlock the Full India to Thailand Gliclazide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 19 shipments on this route.
Frequently Asked Questions — India to Thailand Gliclazide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Gliclazide to Thailand?
The leading Indian exporters of Gliclazide to Thailand are PANACEA BIOTEC PHARMA LIMITED, INVENTIA HEALTHCARE LIMITED, STALLION LABORATORIES PVT LTD. PANACEA BIOTEC PHARMA LIMITED holds the largest market share at approximately 99% of total trade value on this route.
Q What is the total value of Gliclazide exports from India to Thailand?
India exports Gliclazide to Thailand worth approximately $6.2M USD across 19 recorded shipments. The average value per shipment is $325.8K USD.
Q Which ports does India use to ship Gliclazide to Thailand?
The most active port of origin is DELHI AIR with 6 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to Thailand for Gliclazide?
The average transit time for Gliclazide shipments from India to Thailand is approximately 26 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Thailand Gliclazide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.5% with demand growth tracking at 21.5%. The route is ranked #3 among India's top Gliclazide export destinations globally.
Q How many suppliers are active on the India to Thailand Gliclazide route?
There are currently 7 active Indian suppliers exporting Gliclazide to Thailand. The market is moderately concentrated with PANACEA BIOTEC PHARMA LIMITED accounting for 99% of total shipment value.
Q Who are the main importers of Gliclazide from India in Thailand?
The leading importers of Indian Gliclazide in Thailand include M/S. BIOGENETECH CO. LTD,, BIOGENETECH CO. LTD,, M S BIOGENETECH CO LIMITED, REAL VALUE THERAPY PHARMACEUTICALS, VITAL PHARMACEUTICAL CO, LTD.. M/S. BIOGENETECH CO. LTD, is the largest buyer with 1 shipments worth $5.7M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Thailand export trade corridor identified from Indian Customs (DGFT) records for Gliclazide.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 11 importers in Thailand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 19 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
19 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists